Leafly

OCTOBER 4, 2022

A drug that blocks the brain's cannabinoid receptors is now in clinical trials and showing promising results. The post Are you too high? A promising new ‘comedown drug’ may be on the way appeared first on Leafly.

Clinical Trials 103

Clinical Trials Cannabinoids Medicine THC 103

Cannabis Law Report

AUGUST 10, 2022

The lead investigators are Jacobo Mintzer , MD, MBA, Brigid Reynolds , ANP-BC, and the Alzheimer’s Clinical Trial Consortium (ACTC).The ” Study Details – provided by Alzheimer’s Clinical Trial Consortium. MediPharm Labs Corp. Logo (CNW Group/MediPharm Labs Corp.).

Clinical Trials 52

Clinical Trials Medicine Pharmaceutical THC 52

Puff Puff Post

MARCH 10, 2020

InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers. For more information, visit www.inmedpharma.com.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

NOVEMBER 29, 2019

Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. THC is the psychoactive compound in cannabis. But, THC has a similar chemical makeup with cannabidiol or CBD. CBD combats THC’s effects. THC alters communication functions. That’s why some people choose THC oil. THC Oil Benefits.

Oil 104

Oil THC Cannabinoids Research and Development 104

Canna Care Docs

JUNE 22, 2018

An Introductory Lesson on THC Basics For Medical Cannabis Patients. But one of the most famous and most widely known phrases associated with the plant will always be THC, or more appropriately, delta-9-tetrahydrocannabinol. THC Basics: Perceptions in Today’s Society.

THC 66

THC Patients Blood Pressure Clinical Trials 66

Cannabis Law Report

JULY 4, 2021

The level of THC in CBD products should fall below 0.2% Cannabidiol or CBD is one of the most common cannabinoids found in cannabis. Even though CBD is an important component in medicinal cannabis, it is also derived from the hemp plant. What is THC? CBD vs THC. or none at all to qualify with legal status.

THC 105

THC CBD Legalization Oil 105

Cannabis Law Report

MARCH 22, 2020

Mugglehead reports… Previous tests with THC in mice with influenza showed an increase in viral loads. A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. 9:46 AM – Mar 19, 2020.

THC 59

THC Clinical Trials Data Consumption 59

FloridaMarijuana.net

AUGUST 15, 2018

Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. The endocannabinoid system consists of cannabinoid receptors all over the body. These damaged nerve fibers send incorrect signals to other pain centers.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Weedistry

MARCH 7, 2019

Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. But the cancer cells died each time they were exposed to tetrahydrocannabinol ( THC ), the principal psychoactive ingredient of marijuana.

THC 40

THC CBD Clinical Trials Research and Development 40

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

The Cannigma

JUNE 14, 2021

‘Junk’ cannabis ‘ill-suited for clinical trials’. The cannabis grown at the University of Mississippi “is junk, ill-suited for clinical trials, and genetically closer to hemp than the marijuana available from dispensaries and used by Americans nationwide,” according to the lawsuit. A promise made years ago.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

NOVEMBER 24, 2019

Cannabis-based medicinal products. Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

The Cannigma

APRIL 12, 2023

CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. The MoreBetter & CBDistillery CBN study CBN, or cannabinol , is a natural product of THC degradation; it can be found in aged, poorly stored cannabis plants and also in cannabis smoke. Like THC , CBN is a natural anti-inflammatory.

Sleep 133

Sleep Data Tincture Research and Development 133

FloridaMarijuana.net

JUNE 13, 2018

In 1975, The Journal of the National Cancer Institute published a revolutionary study within the medical industry which showed that tumor growth slowed or stopped in laboratory mice after the use of THC and cannabis compounds. Cannabinoids are extracted from the cannabis plant and an extract oil is created.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

SEPTEMBER 22, 2021

Oxford Cannabinoid Technologies Holdings plc. . Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. Accelerated timelines to clinical trials and expansion of drug development pipeline. Phase 1 clinical trials are scheduled for Q3 2022 with Phase 2 trials expected in Q2 2023.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

The Cannigma

FEBRUARY 2, 2021

However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. Parkinson’s disease and cannabis. Interest among patients is high, but knowledge is limited.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

The Joint Blog

APRIL 17, 2020

According to a new study in the Journal of Clinic Medicine , the use of Tetrahydrocannabinol (THC) could have adverse drug effects when combined with other medications due to drug-drug interactions. Its psychoactive ingredient, THC, has made cannabis a highly used recreational drug for millennia. Cannabis Sativa, a.k.a

Events 48

Events THC Chronic Pain Sleep 48

LifeCannMD

FEBRUARY 27, 2024

Moreover, THC (tetrahydrocannabinol) can reduce nausea and stimulate appetite, addressing common symptoms like nausea, loss of appetite, and weight loss. Cannabinoids have been shown to possess anti-inflammatory properties, potentially targeting the inflammation at the root of the disease.

Marijuana 59

Marijuana Clinical Trials Treatment Therapy 59

SpeedWeed

AUGUST 5, 2021

Over the past several months, onlookers have watched heavily hyped, high-inducing cannabinoids divide the hemp industry. As a growing number of states step in to regulate these controversial substances, such as delta-8 tetrahydrocannabinol (THC), multiple cannabinoids join the fray. Dr. Ethan Russo: More the latter.

THC 52

THC Vaping Cannabinoids Blood Pressure 52

United Patients Group

JANUARY 8, 2023

In fact, cannabis has been used for thousands of years as a medicine. This is because it contains cannabinoids, which have anti-inflammatory properties. In order to get involved in research, you can look up clinical trials in your area that may be accepting volunteers. Cannabis and the Immune System. Conclusion.

Blood Pressure 105

Blood Pressure Sleep Cannabinoids Clinical Trials 105

Canna Care Docs

JUNE 18, 2018

CBD is one of close to 85 cannabinoids present in cannabis, with THC being the most commonly known. Cannabinoids are chemicals within cannabis that offer relief to patients, similar to natural compounds in our body called endocannabinoids. An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

Clinical Trials 75

Clinical Trials CBD Epilepsy Patients 75

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Medicinal Marijuana Association

FEBRUARY 11, 2024

THC : This compound has also demonstrated the ability to lower intraocular pressure, offering another avenue for exploring cannabis-based treatments for glaucoma. The anti-inflammatory properties of certain cannabinoids in cannabis could also play a role in protecting retinal cells from damage associated with the condition.

Treatment 52

Treatment Blood Pressure Conditions Clinical Trials 52

The Cannigma

MARCH 18, 2021

Those who use high THC products were 7.43 If cannabis is intended to be used as a medicinal or CAIM (complementary and integrative medicine) treatment for PD, formal recommendations are needed to fill the current knowledge gap around cannabis type, dosage , and efficacy,” the researchers wrote. An overwhelming 84.7%

Patients 138

Patients Clinical Trials Treatment Cannabis 138

The Cannigma

MAY 19, 2021

Medical : Illegal Recreational : Illegal *CBD products are legal in Japan, as long as they contain no THC whatsoever and are not made from cannabis flower. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

DECEMBER 21, 2021

CBGA, an acidic version of CBG, is the stem cell of the cannabis plant, meaning that as the young plant is growing it is producing CBG and as it matures and produces flowers the CBG is converted to THC or CBD or a combination of the two. It occurs because most of the CBG has been converted to CBD and THC as the plant has matured.

Conditions 52

Conditions Research and Development Clinical Trials Oil 52

The Joint Blog

JANUARY 23, 2020

The study is titled “Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.” ” “Medicinal cannabis has received increased research attention over recent years due to loosening global regulatory changes”, states the study’s abstract.

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Veriheal

MAY 3, 2022

Clinical Trial Sample Size. The trial was conducted with just 186 participants, which is far too small of a sample size to provide findings generalizable to the larger population. a necessary question to address as medical marijuana becomes more accessible.

Research and Development 95

Research and Development Clinical Trials Consumption Patients 95

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Acceptance of Medicinal Cannabis. Approved Cannabinoid-Based Medications. Cannabis Cancer Treatments as an Alternative to Opioids.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

FloridaMarijuana.net

AUGUST 15, 2018

Evidence-based Complementary and Alternative Medicine published an article titled “Post-Traumatic Stress Disorder: Evidence-Based Research for the Third Millennium” which describes how profound the symptoms of PTSD can be: “Traumatic events are profoundly stressful.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Cannabis Law Report

JANUARY 19, 2022

With his extensive experience in Congress and as a policy advisor on topics including health, technology, and education, we are confident Congressman Moran will be a great asset to IGC especially at a time when we pursue Phase 2/3 human trials on IGC- AD1 on individuals that have Alzheimer’s disease. www.igcinc.us , www.igcpharma.com.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

APRIL 8, 2019

Through the Narcotic Drugs Amendment Act 2016 (Cth) and its amendments to the Narcotic Drugs Act 1967 (Cth) ( NDA ), the Australian Government commenced the legalisation of medicinal cannabis products in Australia under federal law in 2016. Australia’s medicinal cannabis industry continues to flourish. Chapter 2 of the NDA.

Medicine 71

Medicine Research and Development Business Cannabis 71

The Cannigma

JUNE 20, 2021

The ECS itself is composed of receptors (including CB1 and CB2) that are themselves activated or blocked by the cannabinoids produced within the human body (called “endocannabinoids”). These receptors can also be influenced by the cannabinoids produced by cannabis, known as “phytocannabinoids.” ’” (Shutterstock).

Food 145

Food Terpenes Cannabinoids Clinical Trials 145

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists.

CBD 98

CBD THC Conditions Medicine 98